<DOC>
	<DOCNO>NCT02949037</DOCNO>
	<brief_summary>Multi-site feasibility study design assist type-2 diabetes patient self-care activity . The study include Bluetooth-enabled medical device ( i.e . scale , blood pressure cuff , glucometers , activity monitor ) intervention control group . Those intervention group device link mobile health care environment provide key benefit include : device data trending , reinforce tailored behavioral message , enhance communication clinic .</brief_summary>
	<brief_title>Enhancing mHealth Technology Activate Chronic Care Patients</brief_title>
	<detailed_description>Multi-site phase study , conduct within Military Health System include user-centered design phase patient center medical home ( PCMH ) -based feasibility trial . In Phase I investigators assess patient clinician preference usability regard enhancement enable technology capability Type 2 diabetes chronic self-care management . The data experience cod analyze research team technology adapt accordingly Phase II . Phase II research single-blinded 12-month feasibility study seek include enable technology support diabetes self-care management tailor behavioral messaging aim reinforce encourage self-care behavior base patient ' readiness . We include safety threshold alert patient clinical team certain condition .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Men woman age 18 year old , Ability understand read English , Be empanel one target PCMH sit , Diagnosed type 2 diabetes . pregnant woman , nonEnglish speaking patient , receive hospice care , active cancer treatment chemotherapy radiation therapy , take Coumadin , recipient gastric bypass similar procedure , diagnosis uncontrolled hypothyroidism , know Cushing 's syndrome , treat oral steroid , know liver disease , current diagnosis cognitive impairment would interfere use technology , congestive heart failure NYHA class 3 4 , inability use mobile device due cognitive physical impairment , PAMÂ® score = 4 initial screening .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>